Tags

Type your tag names separated by a space and hit enter

Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture's syndrome.
Isr J Med Sci. 1996 Jan; 32(1):29-31.IJ

Authors+Show Affiliations

Research Unit of Autoimmune Diseases, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

8550343

Citation

Shoenfeld, Y. "Pathogenicity of Anti-basement Membrane (NC1) Antibodies: an Experimental Goodpasture's Syndrome." Israel Journal of Medical Sciences, vol. 32, no. 1, 1996, pp. 29-31.
Shoenfeld Y. Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture's syndrome. Isr J Med Sci. 1996;32(1):29-31.
Shoenfeld, Y. (1996). Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture's syndrome. Israel Journal of Medical Sciences, 32(1), 29-31.
Shoenfeld Y. Pathogenicity of Anti-basement Membrane (NC1) Antibodies: an Experimental Goodpasture's Syndrome. Isr J Med Sci. 1996;32(1):29-31. PubMed PMID: 8550343.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture's syndrome. A1 - Shoenfeld,Y, PY - 1996/1/1/pubmed PY - 1996/1/1/medline PY - 1996/1/1/entrez SP - 29 EP - 31 JF - Israel journal of medical sciences JO - Isr J Med Sci VL - 32 IS - 1 SN - 0021-2180 UR - https://www.unboundmedicine.com/medline/citation/8550343/Pathogenicity_of_anti_basement_membrane__NC1__antibodies:_an_experimental_Goodpasture's_syndrome_ DB - PRIME DP - Unbound Medicine ER -